{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:28Z","timestamp":1787067568216,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"36","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI15C2955"],"award-info":[{"award-number":["HI15C2955"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2015M3A9B5030157"],"award-info":[{"award-number":["NRF-2015M3A9B5030157"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002648","name":"Catholic University of Korea","doi-asserted-by":"publisher","award":["HI15C2971"],"award-info":[{"award-number":["HI15C2971"]}],"id":[{"id":"10.13039\/501100002648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.vaccine.2019.07.070","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T07:51:13Z","timestamp":1564386673000},"page":"5191-5202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1\/Th2 response"],"prefix":"10.1016","volume":"37","author":[{"given":"Hye Won","family":"Kwak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae Li","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyelim","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-3392","authenticated-orcid":false,"given":"Sang-Myeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoon-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Rok","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Ouk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Gwin","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Cheol","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7555-1091","authenticated-orcid":false,"given":"Jae-Hwan","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.07.070_b0005","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(11)60478-9","article-title":"Vaccine production, distribution, access, and uptake","volume":"378","author":"Smith","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.07.070_b0010","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1080\/21645515.2016.1219003","article-title":"Vaccine adjuvants: why and how?","volume":"12","author":"Christensen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.070_b0015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479\u2013480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.07.070_b0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.smim.2018.05.001","article-title":"Correlates of adjuvanticity: a review on adjuvants in licensed vaccines","volume":"39","author":"Del Giudice","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0025","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","article-title":"Mechanisms of action of adjuvants","volume":"4","author":"Awate","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0030","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.07.070_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nri2510","article-title":"Towards an understanding of the adjuvant action of aluminium","volume":"9","author":"Marrack","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0040","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2017.06.005","article-title":"Old and new adjuvants","volume":"47","author":"McKee","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","article-title":"Advances in aluminum hydroxide-based adjuvant research and its mechanism","volume":"11","author":"He","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.07.070_b0050","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.07.070_b0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1586\/14760584.7.3.373","article-title":"Type I interferons as vaccine adjuvants against infectious diseases and cancer","volume":"7","author":"Bracci","year":"2008","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.07.070_b0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/infdis\/122.4.339","article-title":"Enhanced resistance of mice to virulent Japanese B encephalitis virus following inactivated vaccine and poly(I:C)","volume":"122","author":"Singh","year":"1970","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.070_b0065","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1586\/14760584.2015.966085","article-title":"Vaccine adjuvant uses of poly-IC and derivatives","volume":"14","author":"Martins","year":"2015","journal-title":"Expert Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.07.070_b0070","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1084\/jem.20111171","article-title":"Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans","volume":"208","author":"Caskey","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.070_b0075","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.addr.2013.05.013","article-title":"Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant","volume":"65","author":"Hafner","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2019.07.070_b0080","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0085","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1172\/JCI40817","article-title":"Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte\/macrophage population","volume":"120","author":"Antonelli","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.07.070_b0090","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.070_b0095","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02338-12","article-title":"A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant","volume":"87","author":"Martinez-Gil","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0100","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1084\/jem.20171450","article-title":"Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses","volume":"215","author":"Pardi","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.070_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181f7dbe8","article-title":"Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity","volume":"34","author":"Fotin-Mleczek","year":"2011","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2019.07.070_b0110","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.4049\/jimmunol.1601129","article-title":"A new RNA-based adjuvant enhances virus-specific vaccine responses by locally triggering TLR- and RLH-dependent effects","volume":"198","author":"Ziegler","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4014\/jmb.1811.11019","article-title":"Development of an RNA expression platform controlled by viral internal ribosome entry sites","volume":"29","author":"Ko","year":"2019","journal-title":"J Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0120","article-title":"Measurement of neutralizing serum antibodies of patients vaccinated with human papillomavirus L1 or L2-based immunogens using furin-cleaved HPV Pseudovirions","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.07.070_b0125","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.070_b0130","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2019.07.070_b0135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0140","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1128\/JVI.03427-14","article-title":"Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease","volume":"89","author":"Agrawal","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0145","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1021\/mp500426r","article-title":"Peptides used in the delivery of small noncoding RNA","volume":"11","author":"Shukla","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2019.07.070_b0150","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1146\/annurev-immunol-042617-053309","article-title":"RIG-I and other RNA sensors in antiviral immunity","volume":"36","author":"Chow","year":"2018","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0155","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1073\/pnas.1323279111","article-title":"Rapid generation of a mouse model for Middle East respiratory syndrome","volume":"111","author":"Zhao","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.07.070_b0160","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.molimm.2008.12.014","article-title":"Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production","volume":"46","author":"Sofi","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0165","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/0008-5472.CAN-15-1498","article-title":"IL15 and T-cell stemness in T-cell-based cancer immunotherapy","volume":"75","author":"Pilipow","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.vaccine.2019.07.070_b0170","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI0215770","article-title":"IFNs and STATs in innate immunity to microorganisms","volume":"109","author":"Decker","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2019.07.070_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","article-title":"STAT3 signaling in immunity","volume":"31","author":"Hillmer","year":"2016","journal-title":"Cyto Growth Factor Rev"},{"key":"10.1016\/j.vaccine.2019.07.070_b0180","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.1501836","article-title":"A cGAS-independent STING\/IRF7 pathway mediates the immunogenicity of DNA vaccines","volume":"196","author":"Suschak","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0185","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/502972","article-title":"Both CD4+ and CD8+ T cells can mediate vaccine-induced protection against Coccidioides immitis infection in mice","volume":"19","author":"Fierer","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.07.070_b0190","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.1128\/JVI.00039-16","article-title":"Transient CD4+ T cell depletion results in delayed development of functional vaccine-elicited antibody responses","volume":"90","author":"Provine","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.07.070_b0195","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1634\/theoncologist.2008-0097","article-title":"The use of TLR7 and TLR8 ligands for the enhancement of cancer immunotherapy","volume":"13","author":"Smits","year":"2008","journal-title":"Oncologist"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19309910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:31:25Z","timestamp":1778679085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19309910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":39,"journal-issue":{"issue":"36","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0264410X19309910"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.070","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cricket paralysis virus internal ribosome entry site-derived RNA promotes conventional vaccine efficacy by enhancing a balanced Th1\/Th2 response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}